Catalyst Funds Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,600	Closed	-$29.6K	–	1146
2024 Q1	$29.6K	Buy	+1,600	New	+$29.6K	0.01%	672